Taihe Group Inc (TIHE)
3.30
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 237.11M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 1.23% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.95% |
Profile
Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds. |
URL | http://www.oncodocs.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | |
Industry | |
Equity Style | N/A |
Next Earnings Release | Jun. 20, 2024 (est.) |
Last Earnings Release | May. 30, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds. |
URL | http://www.oncodocs.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | |
Industry | |
Equity Style | N/A |
Next Earnings Release | Jun. 20, 2024 (est.) |
Last Earnings Release | May. 30, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |